NPS Pharmaceuticals — Merger or Acquisition (March 2003)
9 slides from NPS Pharmaceuticals's merger presentation, Mar 27, 2003
Slide 1: Science, Pipeline, Products: Creating a Biotechnology Leader
Science, Pipeline, Products: Creating a Biotechnology Leader
Slide 2: To Build a Sustainable Top-Tier Biotech Based On
To Build a Sustainable Top-Tier Biotech Based On: • A deep, diversified and sustainable pipeline • A clearly defined pathway to profitability • A fully integrated infrastructure and stable financial position
Slide 3: Platform
Platform Technologies Preclinical *PEGylation J «SCA Projects *Single-Chain |] * PEG: Antibodies cytoxice) + Inhaled Leuprolide Phase! Phase I Commercialization Phase Ill & Manufacturing + PEG-INTRON * ABELCET * ADAGEN * ONCASPAR *DEPOCYT NPS mm ENZON
Slide 4: Pipeline, Products & Technologies
Pipeline, Products & Technologies
Slide 5: ABELCET, ONCASPAR, DEPOCYT, ADAGEN
• ABELCET ® • ONCASPAR ® • DEPOCYT ® • ADAGEN ®
Slide 6: PREOS (Cinacalcet HCl)
PREOS TM Cinacalcet HCI
Slide 7: Operational Overview
Operational Overview
Slide 8: Locations
Locations Manufacturing: Indianapolis, IN Research: /Toronto, Canada _ Manufacturing: Toronto, Canada Research: Piscataway, NJ Manufacturing: South Plainfield, NJ Headquarters: Research: Bridgewater, NU Salt Lake City, Utah
Slide 9: Science, Pipeline, Products: Creating a Biotechnology Leader
Science, Pipeline, Products: Creating a Biotechnology Leader
NPS Pharmaceuticals — Merger or Acquisition (March 2003) on 6ix